Plasma gastrin and gastric enterochromaffinlike cell activation and proliferation. Studies with omeprazole and ranitidine in intact and antrectomized rats - PubMed (original) (raw)

Plasma gastrin and gastric enterochromaffinlike cell activation and proliferation. Studies with omeprazole and ranitidine in intact and antrectomized rats

H Larsson et al. Gastroenterology. 1986 Feb.

Abstract

Unoperated female rats were subjected to daily oral treatment with omeprazole (10 or 400 mumol/kg body wt), ranitidine (175 + 175 + 350 mumol/kg body wt), or vehicle and antrectomized rats were treated with omeprazole (400 mumol/kg body wt) or vehicle. After 10 wk of treatment, plasma gastrin levels were high in unoperated rats treated with the high omeprazole dose and with ranitidine, and low in antrectomized controls. Plasma gastrin levels were slightly higher in the low-dose omeprazole group than in the intact controls. In antrectomized rats treated with the high dose of omeprazole, the plasma gastrin level was in the same range as in intact control rats. A close correlation (r = 0.89, p less than 0.0001) was found between the plasma gastrin level and the oxyntic mucosal enterochromaffinlike cell density (as well as the tissue levels of histidine decarboxylase and histamine in the oxyntic mucosa) in all groups. The somatostatin cell density in the oxyntic mucosa was not altered by the various treatments. During a recovery period of 10 wk after the 10-wk treatment, the enterochromaffinlike cell density and histamine concentration decreased by 30%-40% in the rats treated with the high dose of omeprazole, whereas the corresponding values increased by 50% and 40%, respectively, in the control rats. The difference between the two groups, however, was still statistically significant. Plasma gastrin levels and gastric histidine decarboxylase activity returned to control values during recovery. The results suggest that the observed changes in enterochromaffinlike cell density are related to the plasma gastrin levels and that they are reversible. it is concluded that neither omeprazole nor ranitidine per se is likely to induce proliferation of enterochromaffinlike cells.

PubMed Disclaimer

Cited by

Unresolved surgical issues in the management of patients with Zollinger-Ellison syndrome.
Norton JA, Jensen RT. Norton JA, et al. World J Surg. 1991 Jan-Feb;15(1):151-9. doi: 10.1007/BF01658992. World J Surg. 1991. PMID: 1671617 Review.
Quantitative electron microscopy of endocrine cells in oxyntic mucosa of normal human stomach.
D'Adda T, Bertelé A, Pilato FP, Bordi C. D'Adda T, et al. Cell Tissue Res. 1989 Jan;255(1):41-8. doi: 10.1007/BF00229064. Cell Tissue Res. 1989. PMID: 2736608
Clofibrate raises human 24 h intragastric acidity but does not affect plasma gastrin concentration.
Gavey CJ, Smith JT, Nwokolo CU, Pounder RE. Gavey CJ, et al. Br J Clin Pharmacol. 1990 Apr;29(4):473-7. doi: 10.1111/j.1365-2125.1990.tb03666.x. Br J Clin Pharmacol. 1990. PMID: 2328195 Free PMC article.
Influence of multiple endocrine neoplasia type 1 on gastric endocrine cells in patients with the Zollinger-Ellison syndrome.
Lehy T, Cadiot G, Mignon M, Ruszniewski P, Bonfils S. Lehy T, et al. Gut. 1992 Sep;33(9):1275-9. doi: 10.1136/gut.33.9.1275. Gut. 1992. PMID: 1358767 Free PMC article.
Acid suppression: how much is needed?
Colin-Jones DG. Colin-Jones DG. BMJ. 1990 Sep 22;301(6752):564-5. doi: 10.1136/bmj.301.6752.564. BMJ. 1990. PMID: 1978697 Free PMC article. No abstract available.

Plasma gastrin and gastric enterochromaffinlike cell activation and proliferation. Studies with omeprazole and ranitidine in intact and antrectomized rats - PubMed (original) (raw)